WEEKLY MARKET OUTLOOK
Great Setups, Uneven Feedback
Weekly Market Outlook | October 11, 2026
GB Capital Weekly Market Outlook · Week of October 12, 2026
Great Setups, Uneven Feedback
Market posture: Bullish
Evidence Score: 4.0 / 5, unchanged from October 5
Exposure bias: Adding exposure where the individual setup confirms
I am still bullish into year end. The indexes keep holding, leadership is broadening into software and cybersecurity and the setup list is still the deepest since April. What changed this week is the feedback, and that is why the score holds at 4.0 instead of moving higher.
The 60 Second Read
The market has refused to break. Treasury yields kept rising, crude oil kept applying pressure and the indexes held together anyway. QQQ held its breakout area and closed at $751.27, about 1.5% below its high. SPY is pressing its high, IWM defended the 200-day again and ARKK closed above both of its major averages.
The setup environment remains one of the best I have seen since April. Software and cybersecurity took over leadership this week, even stronger than the AI infrastructure names, while plenty of AI infrastructure names are still setting up and look great. What changed is the feedback. Nearly identical setups produced very different outcomes: some followed through, some gave the move back after a day or two and others are still unresolved.
That keeps the score at 4.0. I am bullish into year end and still taking valid setups, and I am letting price and position feedback determine where aggression is earned. Breadth remains poor, but the indexes continue to hold together. That divergence is both the risk and the opportunity.
Evidence Continuity
Evidence | October 5 | Current read |
|---|---|---|
Indexes | QQQ broke out of its four-month range; SPY reclaimed its averages; IWM bounced at the 200-day. | QQQ held the breakout area; SPY is pressing its high; IWM defended the 200-day again. |
Leaders | HPE, LITE, SMTC, AMD, MRNA, TER and ANET at or near highs. | Software and cybersecurity took the lead: RBRK, CRWD, OKTA, DDOG, HNGE and SNOW. MRNA, HPE, ANET, LITE and DELL kept working. |
The list | 35 names, with 11 on High Alert. | Still the deepest list since April: 14 on High Alert, with MU and SNDK at make-or-break levels. |
Breadth | Stage 2 fell to 24% and Stage 4 rose to 55%. | Unchanged at 24% and 55%. New lows have outpaced new highs for weeks. |
Themes | Semis +4.85% and genomics +6.05% led the week. | Cybersecurity +7.85% and software +5.81% led; semis slipped 0.93% and genomics fell 5.39%. |
Position feedback | My last two to three entries worked. | Mixed but constructive. HPE followed through; SPCX moved and is flagging; NBIS stayed choppy. |
What I am doing | Pressing harder when a valid setup triggers and starts working. | Still taking valid setups and letting feedback decide where I press. |
GB Capital Market Evidence Dashboard
Evidence | Oct. 5 | Oct. 12 | What changed |
|---|---|---|---|
Primary trend | 4.25 | 4.25 | QQQ and SPY remain above their 50-day and 200-day averages and near their highs. |
Index structure | 4.25 | 4.25 | QQQ held its breakout area 1.5% below its high; SPY is 0.4% from its high; IWM defended the 200-day but remains below its 50-day. |
Stage participation | 1.50 | 1.50 | Stage 2 held at 24% and Stage 4 at 55%. New lows have outpaced new highs for weeks. |
Leadership | 4.75 | 4.75 | Leadership rotated into software and cybersecurity; MRNA, HPE, ANET, LITE and DELL kept working. |
Trend persistence | 4.25 | 4.25 | HPE, MRNA, LITE and RBRK kept pushing higher; other moves faded within days. |
Risk appetite | 4.25 | 4.25 | Cybersecurity, software and ARKK led. Semis and genomics cooled for the week. |
Setup proliferation | 5.00 | 5.00 | Still the best list of quality daily and weekly setups I have seen since April. |
Position feedback | 3.50 | 3.50 | Mixed but constructive. HPE followed through; SPCX faded into a flag; NBIS stayed choppy. |
Composite: 31.75 / 8 = 3.97, shown as 4.0, unchanged from October 5. Scale: 1 defensive, 3 balanced, 5 aggressive.
The bullish evidence survived another week. The indexes held through rising yields and crude pressure, leadership broadened and the setup list stayed deep. That keeps the score from moving lower. Two things keep it from moving higher: breadth did not improve, and realized follow-through was inconsistent. A 5.0 setup score gives me more choices, not permission to lower standards.
Breadth Is Poor. The Indexes Keep Holding.
Breadth did not improve. Stage 2 participation held at 24% and Stage 4 at 55%, and new lows have outpaced new highs for weeks. Friday's count was 325 new lows against 121 new highs, little changed from 343 against 131 the week before. Friday's short-term readings were modestly positive, with 53% of stocks advancing and up-volume names beating down-volume names 90 to 64, but the broader participation structure remains poor. Even Information Technology, the strongest sector, slipped to 34% in Stage 2 from 36% and has 50% in Stage 4.
The indexes did not follow breadth lower. That is the same mismatch I wrote about last week, and it held for another week. If more stocks start moving into Stage 2 while the indexes and the current leaders hold, there is a lot of room for the move to broaden. If the leaders start failing while breadth stays this weak, there is very little underneath to catch them.
Current Breadth and Price Map
Area | Current reading | What it tells me | What I want next |
|---|---|---|---|
QQQ | $751.27 | Holding the breakout area 1.5% below the $762.86 high; above the 50-day ($724.52) and 200-day. | Hold and extend toward and through the high. |
SPY | $778.57 | Above both averages and 0.4% from its $781.62 high. | Clear the high while holding the 50-day ($767.57). |
IWM | $278.94 | Defended the 200-day ($277.06); still below the 50-day ($291.38). | Move away from the 200-day and reclaim shorter averages. |
ARKK | $89.62 | Up 2.31% Friday; above its 50-day and 200-day averages. | Higher beta keeps confirming risk appetite. |
Stage participation | 24% Stage 2 / 55% Stage 4 | Unchanged. The broad market remains weak underneath. | Stage 2 rises above 24%; Stage 4 falls from 55%. |
New highs vs. lows | 121 / 325 (Friday) | New lows have outpaced new highs for weeks, even with the indexes near highs. | The gap narrows without index damage. |
Sentiment | Fear & Greed 45 | Neutral, up from 39 a week ago. Improved, far from euphoric. | No obstacle to the bullish view. |
The read is the same as the headline: the indexes are doing their job, and the average stock has yet to follow. That gap is where the upside can come from if participation turns.
The Names Are Telling the Story
Cybersecurity gained 7.85% and software 5.81% on the week in the DeepVue theme data. Semiconductors slipped 0.93% after gaining 4.85% the prior week, and genomics fell 5.39% after gaining 6.05%. RBRK, CRWD, OKTA, DDOG and HNGE are acting like leaders, and SNOW joined them with Friday's breakout. MRNA kept pushing higher even as genomics fell, which is real relative strength.
One weaker week for semis is no reason to write off the AI infrastructure trade. Several of those names are building some of the best bases on my screen.
Evidence group | Names | What I am watching |
|---|---|---|
Software and cybersecurity | RBRK, CRWD, OKTA, DDOG, HNGE, SNOW | The strongest group. Whether SNOW holds its breakout and the group keeps expanding. |
Established leaders | MRNA, HPE, ANET, LITE, DELL | Use them to judge risk appetite; let pullbacks show whether demand holds. |
Semis and AI connectivity | MRVL, TSEM, TER, ALAB, CRDO | Still setting up well through a down week for semis; resolutions need to hold past day two. |
Optical and AI hardware | GLW, COHR, CLS | Same AI spending theme as LITE, ANET and DELL; take the cleanest trigger, not all three. |
Other higher beta | BE, DOCN, OUST, SPCX, HOOD, MSTR | SPCX is rebuilding a flag after two up sessions; HOOD is sitting on its 50-day. |
High Alert (14): MRVL, BE, DOCN, GLW, OUST, SPCX, TSEM, TER, HOOD, COHR, MSTR, ALAB, CLS and CRDO. Make or break: MU and SNDK are sitting at the levels that decide whether memory leadership is stabilizing or deteriorating. Named securities are market evidence, not recommendations.
What Matters and What Can Be Ignored
Bank earnings start this week, and September CPI and retail sales may move rate expectations. Long-term yields remain elevated, mortgage rates are near 7.5% and questions persist about market concentration and the financing needs of AI infrastructure. Despite those pressures, the indexes remain near their highs. That resilience, not the calendar itself, is the evidence that matters.
What matters: whether breakouts hold past the first one or two sessions, whether the leaders keep expanding and whether participation starts to turn.
What matters: whether IWM moves away from the 200-day instead of testing it again.
What can be ignored: the headline itself. CPI, earnings, yields and oil matter only to the extent that they change price, leadership, breadth or position feedback.
What can be ignored: one weak week for a theme that still has quality bases setting up.
What Would Strengthen or Weaken the View
Area | More confidence | I slow down |
|---|---|---|
Indexes | QQQ and SPY extend toward or through their highs. | QQQ loses its breakout structure or SPY loses the 50-day. |
Small caps | IWM moves decisively above the 200-day and reclaims shorter averages. | IWM loses the 200-day decisively. |
Breadth | Stage 2 rises above 24%, Stage 4 falls from 55% and new highs gain on new lows. | Stage 4 keeps expanding and the indexes finally follow breadth lower. |
Leaders | The leaders keep expanding and SNOW holds its breakout. | Leaders begin failing together or SNOW immediately loses its breakout. |
My positions | Position feedback turns consistently positive across multiple entries. | Failed breakouts become more common than successful resolutions. |
Setup quality | More High Alert names resolve and hold; MU and SNDK stabilize. | The High Alert list contracts or MU and SNDK break down. |
I do not need every stock to work. I need the breakouts I take to hold, the indexes to stay near their highs and IWM to move away from the 200-day. Position feedback is what earns more aggression.
What I'm Doing With This Information
I am still taking valid setups rather than waiting for perfect breadth. I buy tightness inside the base near the 8 and 21-day EMAs or other support, with intraday confirmation, and I want an obvious place to be wrong. A full-size entry should be green by the close or I reduce or exit. I trim 20% to 30% into the initial move and let the rest work while the 21-day trend holds.
The difference this week is selectivity. Similar-looking setups are resolving differently, so I am adding aggressively only where the individual setup confirms and position feedback supports it. The deep setup list is evidence of opportunity, not proof that every name will work. I will reduce aggression if failed breakouts start spreading through the leaders or the setup list contracts.
What I'm Watching This Week
Do QQQ and SPY keep holding near their highs?
Can IWM move away from the 200-day instead of testing it again?
Does SNOW's breakout hold, and do the current leaders keep extending?
Do the High Alert setups resolve with better follow-through than last week?
Do new highs start gaining on new lows, and does Stage 2 finally expand from 24%?
Do MU and SNDK stabilize at their make-or-break levels?
Bottom Line
The market has refused to break, the setup list is still the best since April and leadership is broadening into software and cybersecurity. Breadth is still poor and follow-through has been uneven, so the score holds at 4.0 instead of moving higher.
I am bullish into year end and still taking valid setups. Now I want to see breakouts hold and positions work, and I will let that feedback decide where I press.
Research Basis
DeepVue stage, theme and breadth data; TradingView chart evidence; CNN Fear & Greed Index; GB Capital research through the October 9, 2026 close.
For informational purposes only. This material reflects market research and commentary and is not individualized investment advice or a recommendation to buy or sell any security. Named securities are evidence, not recommendations. The author may hold positions in securities discussed.